Randolph v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided October 6, 2020·No. 18-1231·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 18-1231V (Not to be published)

************************* DON RANDOLPH, * * Petitioner, * Filed: September 8, 2020 * v. * Attorney’s Fees and Costs; * Final Award SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * *************************

Lawrence R. Cohen, Anapol Weiss, PA, for Petitioner.

Claudia Barnes Gangi, U.S. Dep’t of Justice, Washington, DC, for Respondent.

DECISION GRANTING FINAL AWARD OF ATTORNEY’S FEES AND COSTS 1

On August 16, 2018, Don Randolph filed a petition seeking compensation under the National Vaccine Injury Compensation Program (“Vaccine Program”) 2 alleging that he developed Guillain-Barré syndrome (“GBS”) from the receipt of the influenza (“flu”) vaccine he received on September 22, 2014. Petition (ECF No. 1) at 1. Based on a thorough review of the record and all submissions, I granted Respondent’s motion to dismiss the case for untimeliness. Petitioner’s claim had been filed nearly four years from the alleged onset date, and therefore was facially

1 Although this Decision has been formally designated “not to be published,” it will nevertheless be posted on the Court of Federal Claims’ website in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 (2012). This means that the Decision will be available to anyone with access to the internet. As provided by 42 U.S.C. § 300aa- 12(d)(4)(B), however, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755 (codified as amended at 42 U.S.C. §§ 300aa-10–34 (2012)) (hereinafter “Vaccine Act” or “the Act”). All subsequent references to sections of the Vaccine Act shall be to the pertinent subparagraph of 42 U.S.C. § 300aa. untimely under the Vaccine Act’s 36-month statute of limitations. Decision (ECF No. 14) at 2. Petitioner otherwise could not avail himself of the Act’s “lookback” provision, because he could not meet the onset requirements for a Table flu-GBS claim.

Petitioner has now filed a motion for a final award of attorney’s fees and costs. Motion for Attorney’s Fees and Costs, filed July 30, 2020 (ECF No. 20) (“Fees App.”). Petitioner requests a final award of $29,699.97—$27,754.10 in attorney’s fees, plus $1,945.87 in costs—for the work of two attorneys (Mr. Lawrence R. Cohen and Mr. David J. Carney) as well as the supportive work of one paralegal. Ex.20, filed on July 30, 2020 (ECF No. 20) at 11. The costs requested include legal research charges, medical record retrieval, court filings, and PACER research fees. Id.

Respondent reacted to the fees request on August 13, 2020. See Response, dated August 13, 2020 (ECF No. 21). Respondent is satisfied that the statutory requirements for an attorney’s fees and costs award are met in this case, and otherwise defers to my discretion the calculation of a proper amount to be awarded. Id. at 2, 3.

ANALYSIS

I. Petitioner’s Claim had Reasonable Basis

Under the Vaccine Act, a special master may award fees and costs to an unsuccessful petitioner if: (1) the “petition was brought in good faith”; and (2) “there was a reasonable basis for the claim for which the petition was brought.” Section 15(e)(1). I have in prior decisions set forth at length the criteria to be applied when determining if a claim possessed “reasonable basis” sufficient for a fees award. See, e.g., Sterling v. Sec’y of Health & Hum. Servs., No. 16-551V, slip op. at 5 (Fed. Cl. Spec. Mstr. Jan. 3, 2020). In short, the claim’s reasonable basis must be demonstrated through some objective evidentiary showing. Cottingham v. Sec’y of Health & Hum. Servs., No. 19-1596, slip. op. at 9–10 (Fed. Cir. 2020) (citing Simmons v. Sec’y of Health & Hum. Servs., 875 F.3d 632, 635 (Fed. Cir. 2017)). This objective inquiry is focused on the claim— counsel’s conduct is irrelevant (although it may bulwark good faith). Simmons, 875 F.3d at 635. Reasonable basis inquiries are not static—they evaluate not only what was known at the time the petition was filed, but also take into account what is learned about the evidentiary support for the claim as the matter progresses. Perreira v. Sec’y of Health & Hum. Servs., 33 F.3d 1375, 1377 (Fed. Cir. 1994) (upholding the finding that a reasonable basis for petitioners’ claims ceased to exist once they had reviewed their expert's opinion, which consisted entirely of unsupported speculation).

The standard for reasonable basis is lesser (and thus inherently easier to satisfy) than the preponderant standard applied when assessing entitlement, as cases that fail can still have sufficient objective grounding for a fees award. Braun v. Sec’y of Health & Hum. Servs., 144 Fed. Cl. 72, 77 (Fed. Cl. 2019). Under the Vaccine Act, special masters have “maximum discretion” in

2 applying the reasonable basis standard. See, e.g., Silva v. Sec’y of Health & Hum. Servs., 108 Fed. Cl. 401, 401–02 (Fed. Cl. 2012). 3 The Court of Federal Claims has affirmed that “[r]easonable basis is a standard that petitioners, at least generally, meet by submitting evidence.” Chuisano v. Sec’y of Health & Hum. Servs., 116 Fed. Cl. 276, 287 (Fed. Cl. 2014) (internal quotations omitted) (affirming special master). The factual basis and medical support for the claim is among the evidence that should be considered. Carter v. Sec’y of Health & Hum. Servs., 132 Fed. Cl. 372, 378 (Fed. Cl. 2017).

Although it did not ultimately succeed, Petitioner’s claim had sufficient objective basis to entitle him to a fees and costs award. See, e.g., P.M. v. Sec’y of Health & Hum. Servs., No. 16- 949V, 2020 WL 1130353, at *1 (Fed. Cl. Spec. Mstr. Feb. 5, 2020). Claims that vaccines can cause GBS are common enough in the Program to have facial credibility, and there was objective support in the record for core matters like proof of vaccination and the nature of Petitioner’s injury. In addition, the claim’s success turned largely on a novel legal question – the scope of the lookback provision, and whether it applies not only to Table claims but untimely non-Table claims as well – and the resolution of that question was far from a foregone conclusion, making it reasonably- litigated. Respondent for her part does not otherwise contest reasonable basis. Accordingly, a final award of fees and costs in this matter is appropriate.

II. Calculation of Fees

Determining the appropriate amount of the fees award is a two-part process. The first part involves application of the lodestar method—“multiplying the number of hours reasonably expended on the litigation times a reasonable hourly rate.” Avera v. Sec’y of Health & Hum.

Free access — add to your briefcase to read the full text and ask questions with AI

Randolph v. Secretary of Health and Human Services, (uscfc 2020).

Randolph v. Secretary of Health and Human Services (Randolph v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related